SCHEMBL6421055

SCHEMBL6421055

NC(=O)n1c(=O)[nH]c2nc[c]cc21

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21054797 0.73 PDE3B (0.41) DAO
SCHEMBL21250167 0.68 PDE3B (0.33) DAO
SCHEMBL7702540 0.60 DAO (0.55) DAO
SCHEMBL29410020 0.58 GRIN1 (0.36) DAO
SCHEMBL28550669 0.58 DAO (0.63) DAO
SCHEMBL1948642 0.58 TYRO3 (0.44)
SCHEMBL28906733 0.58 ALDH1A1 (0.35) DAO
SCHEMBL31648205 0.56 GAA (0.33)
SCHEMBL17113560 0.56 CA12 (0.35)
SCHEMBL21053957 0.54 LMNA (0.50) DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004133-A1 Modulators of VR1 receptor VERTEX PHARMACEUTICALS INCORPORATED 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004133-A1 Modulators of VR1 receptor TRPV1, TRPV2, TRPV3 DAO 4501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.